JUAN FRANCISCO
ARENILLAS LARA

2024

1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

2. A systematic review of the socioeconomic impact of mechanical thrombectomy for acute ischemic stroke

   Journal of Stroke and Cerebrovascular Diseases, Vol. 33, Núm. 11

3. Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial

   Annals of Neurology, Vol. 96, Núm. 5, pp. 887-894

4. Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study

   Journal of Clinical Medicine, Vol. 13, Núm. 6

5. Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study

   Journal of Clinical Medicine, Vol. 13, Núm. 14

6. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

   Journal of NeuroInterventional Surgery, pp. 1-8

7. Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized controlled trial

   Nutrition and Diabetes, Vol. 14, Núm. 1

8. Embolic Events in Infective Endocarditis: A Comprehensive Review

   Reviews in Cardiovascular Medicine, Vol. 25, Núm. 3

9. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial

   JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335

10. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

    JAMA, Vol. 331, Núm. 9, pp. 750-763

11. Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

    The Lancet, Vol. 403, Núm. 10428, pp. 731-740

12. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

13. Pathology-based brain arterial disease phenotypes and their radiographic correlates

    Journal of Stroke and Cerebrovascular Diseases, Vol. 33, Núm. 6

14. Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial

    International Journal of Stroke, Vol. 19, Núm. 1, pp. 120-126

15. Pilot Study Assessing the Safety and Acceptance of a Novel Virtual Reality System to Improve Visual Function

    Seminars in Ophthalmology, Vol. 39, Núm. 5, pp. 394-399

16. Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke

    European Journal of Neurology

17. Randomized Controlled Trial to Assess the Feasibility of a Novel Clinical Decision Support System Based on the Automatic Generation of Alerts through Remote Patient Monitoring

    Journal of Clinical Medicine, Vol. 13, Núm. 19

18. Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

    Stroke, Vol. 55, Núm. 10, pp. 2462-2471

19. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

    The Lancet Neurology, Vol. 23, Núm. 8, pp. 775-786

20. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

    The Lancet, Vol. 403, Núm. 10444, pp. 2597-2605